Table 1. Demographic and clinical characteristic descriptions for esophageal carcinoma patients in different datasets.
| Characteristics | TCGA | GSE53625 |
| Number of samples | 159 | 179 |
| Median survival time (95%CI) (Days) | 536 (468-605) | 1088 (986-1189) |
| Number of death (%) | 63 (39.6) | 106 (59) |
| Age (years) | 62.3 (±12.1) | 59 (±9) |
| Histology type (%) | ||
| Esophagus adenocarcinoma | 79 (49.6) | - |
| Esophagus squamous cell carcinoma | 80 (50.4) | - |
| unknown | - | 179 (100) |
| Stage_T (%) | ||
| T1 | 25 (15.7) | 12 (6.7) |
| T2 | 40 (25.2) | 27 (15.1) |
| T3 | 87 (54.7) | 110 (61.5) |
| T4 | 5 (3.1) | 30 (16.8) |
| TX | 2 (1.3) | 0 (0) |
| Stage_N (%) | ||
| N0 | 64 (40.3) | 83 (46.4) |
| N1 | 69 (43.4) | 62 (34.6) |
| N2 | 9 (5.7) | 22 (12.3) |
| N3 | 5 (3.1) | 12 (6.7) |
| NX | 12 (7.5) | 0 (0) |
| Stage_M (%) | ||
| M0 | 126 (79.2) | 0 (0) |
| M1 | 15 (9.4) | 0 (0) |
| MX | 15 (9.4) | 0 (0) |
| unknow | 2 (2) | 179 (100) |
| Stage (%) | ||
| Stage I | 16 (10) | 10 (5.6) |
| Stage II | 71 (44.7) | 77 (43) |
| Stage III | 54 (34) | 92 (51.4) |
| Stage IV | 14 (8.8) | 0 (0) |
| unknow | 4 (2.5) | 0 (0) |